1. "Molecular Imaging and Therapy Service"
Formats
  1. Journal Article (1812)
  2. Meeting Abstract (932)
  3. Book Section (169)
  4. Review (156)
  5. Editorial (44)
  6. Conference Paper (40)
  7. Guidelines (31)
  8. Miscellaneous (18)
  9. Correspondence (12)
  10. Research Letter (11)
  11. Book Whole (5)
Groups
  1. Molecular Imaging and Therapy Service (3230)
  2. Radiology, Department of (3052)
  3. GSK Faculty (1475)
  4. Sloan Kettering Institute Faculty (1241)
  5. Molecular Pharmacology and Chemistry Program Faculty (1226)
  6. Department of Medicine (983)

More Groups

People
  1. Steven Larson (957)
  2. Heiko Schoder (543)
  3. Neeta Pandit-Taskar (342)
  4. John Humm (281)
  5. Hebert Vargas Alvarez (267)
  6. Lisa Bodei (205)

More People

Years
  1. 2025 (40)
  2. 2024 (129)
  3. 2023 (176)
  4. 2022 (175)
  5. 2021 (197)
  6. 2020 (195)

More Years

Publications
  1. Journal of Nuclear Medicine (569)
  2. Journal of Clinical Oncology (248)
  3. European Journal of Nuclear Medicine and Molecular Imaging (130)
  4. Blood (97)
  5. International Journal of Radiation Oncology, Biology, Physics (73)
  6. Clinical Nuclear Medicine (72)

More Publications

Publishers
  1. Society of Nuclear Medicine (569)
  2. Springer (430)
  3. Elsevier Inc. (303)
  4. American Society of Clinical Oncology (259)
  5. Lippincott Williams & Wilkins (154)
  6. American Association for Cancer Research (150)

More Publishers

Results (3230)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Diagnostic applications of nuclear medicine: Neuroendocrine tumors
    Book Section

    Bodei, L.; Kidd, M.; Gilardi, L.; Volterrani, D.; Paganelli, G.; Grana, C. M.; Modlin, I. M.
    In Strauss, H. W.; Mariani, G.; Volterrani, D.; Larson, S. M. (Eds.) Nuclear Oncology: From Pathophysiology to Clinical Applications. 2nd ed (2017)

    Fulltext@MSK | Save
  • Diagnostic applications of nuclear medicine: Vulvar cancer
    Book Section

    Mahajan, S.; Ma, W.; Pandit-Taskar, N.
    In Strauss, H. W.; Mariani, G.; Volterrani, D.; Larson, S. M. (Eds.) Nuclear Oncology: From Pathophysiology to Clinical Applications. 2nd ed (2017)

    Fulltext@MSK | Save
  • Diagnostic applications of nuclear medicine: Uterine cancers
    Book Section

    Pandit-Taskar, N.; Mahajan, S.; Ma, W.
    In Strauss, H. W.; Mariani, G.; Volterrani, D.; Larson, S. M. (Eds.) Nuclear Oncology: From Pathophysiology to Clinical Applications. 2nd ed (2017)

    Fulltext@MSK | Save
  • Diagnostic applications of nuclear medicine: Ovarian cancer
    Book Section

    Pandit-Taskar, N.; Mahajan, S.; Ma, W.
    In Strauss, H. W.; Mariani, G.; Volterrani, D.; Larson, S. M. (Eds.) Nuclear Oncology: From Pathophysiology to Clinical Applications. 2nd ed (2017)

    Fulltext@MSK | Save
  • Nuclear oncology: From pathophysiology to clinical applications. 2nd ed
    Book Whole


    Springer (2017)

    Fulltext@MSK | Save
  • Cancer biology of molecular imaging
    Book Section

    Larson, S. M.
    In Strauss, H. W.; Mariani, G.; Volterrani, D.; Larson, S. M. (Eds.) Nuclear Oncology: From Pathophysiology to Clinical Applications. 2nd ed (2017)

    Fulltext@MSK | Save
  • Role of nuclear medicine in diagnosis and management of hepatopancreatobiliary disease
    Book Section

    Krebs, S.; Dunphy, M.
    In Jarnagin, W. R.; Allen, P. J.; Chapman, W. C.; D'Angelica, M. I.; DeMatteo, R. P.; Do, R. K. G.; Vauthey, J. N.; Blumgart, L. H. (Eds.) Blumgart's Surgery of the Liver, Biliary Tract and Pancreas. 6th ed (2017)

    Fulltext@MSK | Save
  • A phase Ib/IIa trial of the combination of romidepsin, lenalidomide and carfilzomib in patients with relapsed/refractory lymphoma shows complete responses in relapsed and refractory B-and T-cell lymphomas
    Meeting Abstract

    Mehta-Shah, N.; Moskowitz, A. J.; Lunning, M. A.; Lynch, P.; Scheuerman, M.; Minnal, V.; Galasso, N.; Kumar, A.; Gerecitano, J.; Zelenetz, A. D.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • A pilot study of brentuximab vedotin and AVD chemotherapy followed by 20 Gy involved-site radiotherapy in early stage, unfavorable risk Hodgkin lymphoma
    Meeting Abstract

    Kumar, A.; Casulo, C.; Advani, R. H.; Budde, L.; Barr, P. M.; Batlevi, C. L.; Caron, P.; Chen, R. W.; Constine, L. S.; Courtien, A.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Prognostic utility of serum TARC, MDC, IL10, and soluble CD163 levels with positron emission tomography (PET) response-adapted therapy for advanced-stage Hodgkin lymphoma (HL): A SWOG S0816 US Intergroup correlative study
    Meeting Abstract

    Hsi, E. D.; Li, H.; Nixon, A. B.; Evens, A. M.; Schoder, H.; Straus, D. J.; Bartlett, N. L.; Sweetenham, J. W.; Barr, P. M.; Fanale, M. A.; more...
    Blood (2017)

    Fulltext@MSK | Save